Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Symporters | 1 | 2022 | 362 | 0.680 |
Why?
|
| Absorbable Implants | 2 | 2016 | 342 | 0.550 |
Why?
|
| Femoral Artery | 2 | 2015 | 845 | 0.470 |
Why?
|
| Angina Pectoris | 1 | 2017 | 977 | 0.450 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2015 | 319 | 0.450 |
Why?
|
| Stents | 2 | 2015 | 3280 | 0.440 |
Why?
|
| Hyperlipoproteinemia Type II | 2 | 2015 | 373 | 0.390 |
Why?
|
| Paclitaxel | 2 | 2015 | 1708 | 0.380 |
Why?
|
| Coronary Angiography | 4 | 2023 | 4577 | 0.360 |
Why?
|
| Cardiovascular Agents | 1 | 2015 | 850 | 0.330 |
Why?
|
| Coronary Stenosis | 1 | 2015 | 834 | 0.330 |
Why?
|
| Peripheral Arterial Disease | 2 | 2015 | 1188 | 0.300 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2015 | 1873 | 0.300 |
Why?
|
| Wound Healing | 2 | 2015 | 2785 | 0.300 |
Why?
|
| Neointima | 2 | 2016 | 135 | 0.260 |
Why?
|
| Endovascular Procedures | 1 | 2015 | 1979 | 0.200 |
Why?
|
| Coronary Vasospasm | 1 | 2022 | 88 | 0.200 |
Why?
|
| Aortic Valve Stenosis | 2 | 2024 | 1965 | 0.190 |
Why?
|
| Metals | 2 | 2015 | 719 | 0.190 |
Why?
|
| Anthracyclines | 1 | 2022 | 288 | 0.180 |
Why?
|
| Pericardial Effusion | 1 | 2021 | 247 | 0.170 |
Why?
|
| Polymers | 2 | 2016 | 1621 | 0.160 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 15165 | 0.160 |
Why?
|
| Swine | 4 | 2016 | 5917 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 11725 | 0.160 |
Why?
|
| Heart Failure | 1 | 2022 | 10900 | 0.160 |
Why?
|
| Atherosclerosis | 2 | 2023 | 3445 | 0.150 |
Why?
|
| Sodium | 1 | 2022 | 1623 | 0.140 |
Why?
|
| Hypercholesterolemia | 1 | 2023 | 1151 | 0.140 |
Why?
|
| Cocaine-Related Disorders | 1 | 2018 | 460 | 0.130 |
Why?
|
| Atherectomy | 1 | 2014 | 47 | 0.130 |
Why?
|
| Myocarditis | 1 | 2022 | 771 | 0.130 |
Why?
|
| Constriction, Pathologic | 2 | 2015 | 1107 | 0.120 |
Why?
|
| Ventricular Function, Left | 2 | 2024 | 3670 | 0.120 |
Why?
|
| Standard of Care | 1 | 2017 | 564 | 0.110 |
Why?
|
| Myocardial Revascularization | 1 | 2017 | 841 | 0.110 |
Why?
|
| Sympathectomy | 1 | 2013 | 89 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2018 | 1240 | 0.110 |
Why?
|
| Swine, Miniature | 1 | 2015 | 961 | 0.110 |
Why?
|
| Fibrin | 1 | 2015 | 506 | 0.110 |
Why?
|
| Sus scrofa | 1 | 2013 | 437 | 0.100 |
Why?
|
| Chest Pain | 1 | 2018 | 1114 | 0.100 |
Why?
|
| Renal Artery | 1 | 2013 | 398 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 1519 | 0.100 |
Why?
|
| Tissue Distribution | 1 | 2015 | 2327 | 0.100 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2014 | 624 | 0.090 |
Why?
|
| Angioplasty, Balloon | 1 | 2014 | 653 | 0.090 |
Why?
|
| Glucose | 1 | 2022 | 4397 | 0.090 |
Why?
|
| Drug-Eluting Stents | 1 | 2016 | 753 | 0.090 |
Why?
|
| Coronary Vessels | 2 | 2023 | 3107 | 0.090 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1518 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 3 | 2016 | 2657 | 0.080 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 956 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2015 | 18029 | 0.080 |
Why?
|
| Acute Disease | 1 | 2017 | 7149 | 0.070 |
Why?
|
| Radiography | 1 | 2015 | 7023 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 9959 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 6487 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 11727 | 0.050 |
Why?
|
| Nitrates | 1 | 2022 | 265 | 0.050 |
Why?
|
| Myocardium | 2 | 2024 | 4776 | 0.050 |
Why?
|
| Thorax | 1 | 2023 | 547 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2013 | 2758 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 14722 | 0.040 |
Why?
|
| Humans | 13 | 2024 | 744343 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 13102 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2022 | 690 | 0.040 |
Why?
|
| Models, Animal | 2 | 2016 | 2171 | 0.040 |
Why?
|
| Troponin T | 1 | 2022 | 754 | 0.040 |
Why?
|
| Animals | 5 | 2016 | 168757 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2023 | 8642 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2022 | 1619 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2023 | 15076 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2017 | 23338 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2016 | 2255 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2024 | 1922 | 0.030 |
Why?
|
| Time Factors | 1 | 2015 | 40075 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 21683 | 0.030 |
Why?
|
| Echocardiography | 1 | 2024 | 5102 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2013 | 514 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2023 | 20129 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2022 | 5007 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2013 | 691 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2022 | 77449 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 1486 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2023 | 21746 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2013 | 1774 | 0.020 |
Why?
|
| Aged | 3 | 2023 | 163280 | 0.020 |
Why?
|
| Middle Aged | 3 | 2023 | 213383 | 0.010 |
Why?
|
| Male | 3 | 2023 | 350118 | 0.010 |
Why?
|
| Age Factors | 1 | 2016 | 18370 | 0.010 |
Why?
|
| Kidney | 1 | 2013 | 7186 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2022 | 57776 | 0.010 |
Why?
|
| Female | 2 | 2023 | 380194 | 0.010 |
Why?
|
| Hypertension | 1 | 2013 | 8480 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 63114 | 0.010 |
Why?
|
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_